Description: Zelda Therapeutics is an Australian-based bio-pharmaceutical company that has secured exclusive, global access to an extensive set of human data related to medicinal cannabis based formulations and treatment protocols.
Home Page: zeliratx.com
101 St Georges Terrace
Perth,
WA
6000
Australia
Phone:
61 8 6558 0886
Officers
| Name | Title |
|---|---|
| Mr. Osagie O. Imasogie Esq. | Founder & Chairman |
| Dr. Oludare Odumosu | MD, Global CEO & Director |
| Mr. Greg Blake | Executive Director |
| Mr. Timothy Ryan Slate | Company Secretary & Non-Executive Director |
| Mr. Rahul Ganesan | Vice President of Finance & Accounting |
| Dr. Patty Washer | Clinical Trial Consultant |
Exchange: OTCQB
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.3865 |
| Price-to-Sales TTM: | 45.7152 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 0 |